FDA Preempts “Failure-To-Warn” Pharmaceutical Liability Claims
By James Dabney Miller, a partner in the Washington, D.C. office of the law firm King & Spalding LLP.
By James Dabney Miller, a partner in the Washington, D.C. office of the law firm King & Spalding LLP.